Should Women Be Able to Abort a Fetus Just Because It’s Female?
By Emma Green,
The Atlantic
| 05. 16. 2016
Over the past year, Indiana hasn’t exactly been a leader in anti-discrimination law. Last spring, the state faced massive protests and boycott threats for legislation that may have facilitated discrimination against lesbian, gay, bisexual, and transgender people. And this winter, nascent efforts to pass LGBT protections in hiring, housing, and public accommodations quickly failed.
But in March, the state did pass nearly unprecedented discrimination protections for one group: unborn fetuses. The new law prohibits abortions sought because of “race, color, national origin, ancestry, sex, or diagnosis or potential diagnosis of the fetus having Down syndrome or any other disability.” Doctors who perform them can be held liable in a lawsuit and sanctioned by Indiana’s medical boards.
Pro-life advocates celebrated the law’s passage. Indiana’s legislators wanted to make sure “ours is a policy that values life no matter who you are, where you come from or what your disability might be,” as the bill’s sponsor, Casey Cox, said.
But whether they intended to or not, these lawmakers exposed a set of difficult moral questions that pro-choice progressives tend to ignore in...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Susanna Smith, Genetic Frontiers | 07.28.2025
Key Topics
How does the American far right view genetics and genetic technologies?
What is the history of the American cultural pursuit of trying to choose smarter children? What has science shown us about the relationship of heredity and intelligence...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...